{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:11:53Z","timestamp":1777425113648,"version":"3.51.4"},"reference-count":28,"publisher":"China Science Publishing & Media Ltd.","issue":"7","license":[{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670194"],"award-info":[{"award-number":["81670194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570190"],"award-info":[{"award-number":["81570190"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81529001"],"award-info":[{"award-number":["81529001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600174"],"award-info":[{"award-number":["81600174"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2018,4,1]]},"DOI":"10.1093\/abbs\/gmy047","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T11:08:31Z","timestamp":1522840111000},"page":"643-650","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["DCZ3301, a novel aryl-guanidino inhibitor, induces cell apoptosis and cell cycle arrest via suppressing the PI3K\/AKT pathway in T-cell leukemia\/lymphoma"],"prefix":"10.3724","volume":"50","author":[{"given":"Wenqin","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongsheng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiqun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuaikang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houcai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiucai","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jumei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiliang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2026","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"key":"null","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood-2005-03-1306","volume":"107","author":"Rizvi MA","year":"2006","unstructured":"Rizvi MA, Evens AM, Tallman MS, Nelson BP, Rosen ST. T-cell non-Hodgkin lymphoma. Blood, 2006, 107: 1255-1264.","journal-title":"Blood"},{"key":"null","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1158\/1078-0432.CCR-14-1532","volume":"20","author":"Ravi D","year":"2014","unstructured":"Ravi D, Bhalla S, Gartenhaus RB, Crombie J, Kandela I, Sharma J, Mazar A. The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models. Clin Cancer Res, 2014, 20: 6023-6033.","journal-title":"Clin Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"Shimoyama M","year":"1991","unstructured":"Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387). Br J Haematol, 1991, 79: 428-437.","journal-title":"Br J Haematol"},{"key":"null","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/oxfordjournals.annonc.a057673","volume":"1","author":"Coiffier B","year":"1990","unstructured":"Coiffier B, Brousse N, Peuchmaur M, Berger F, Gisselbrecht C, Bryon PADiebold J. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d\u2019Etude des Lymphomes Agressives). Ann Oncol, 1990, 1: 45-50.","journal-title":"Ann Oncol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/leu.2013.366","volume":"28","author":"Koyama D","year":"2014","unstructured":"Koyama D, Kikuchi J, Hiraoka N, Wada T, Kurosawa H, Chiba SFurukawa Y. Proteasome inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repression of Notch1 in T-cell acute lymphoblastic leukemia. Leukemia, 2014, 28: 1216-1226.","journal-title":"Leukemia"},{"key":"null","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.leukres.2013.10.011","volume":"38","author":"Yosifov DY","year":"2014","unstructured":"Yosifov DY, Kaloyanov KA, Guenova ML, Prisadashka K, Balabanova MB, Berger MRKonstantinov SM. Alkylphosphocholines and curcumin induce programmed cell death in cutaneous T-cell lymphoma cell lines. Leuk Res, 2014, 38: 49-56.","journal-title":"Leuk Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","volume":"108","author":"Johnstone RW","year":"2002","unstructured":"Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell, 2002, 108: 153-164.","journal-title":"Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1182\/blood-2007-11-121913","volume":"111","author":"Moarbess G","year":"2008","unstructured":"Moarbess G, El-Hajj H, Kfoury Y, El-Sabban ME, Lepelletier Y, Hermine O, Deleuze-Masquefa C. EAPB0203, a member of the imidazoquinoxaline family, inhibits growth and induces caspase-dependent apoptosis in T-cell lymphomas and HTLV-I-associated adult T-cell leukemia\/lymphoma. Blood, 2008, 111: 3770-3777.","journal-title":"Blood"},{"key":"null","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1182\/blood-2009-03-210989","volume":"113","author":"Marneros AG","year":"2009","unstructured":"Marneros AG, Grossman ME, Silvers DN, Husain S, Nuovo GJ, MacGregor-Cortelli B, Neylon E. Pralatrexate-induced tumor cell apoptosis in the epidermis of a patient with HTLV-1 adult T-cell lymphoma\/leukemia causing skin erosions. Blood, 2009, 113: 6338-6341.","journal-title":"Blood"},{"key":"null","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/abbs\/gmu030","volume":"46","author":"Gao MJ","year":"2014","unstructured":"Gao MJ, Gao L, Tao Y, Hou J, Yang G, Wu XS, Xu HW. Proteasome inhibitor carfilzomib interacts synergistically with histone deacetylase inhibitor vorinostat in Jurkat T-leukemia cells. Acta Biochim Biophys Sin, 2014, 46: 484-491.","journal-title":"Acta Biochim Biophys Sin"},{"key":"null","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1182\/blood-2004-01-0240","volume":"105","author":"Smith PG","year":"2005","unstructured":"Smith PG, Wang F, Wilkinson KN, Savage KJ, Klein U, Neuberg DS, Bollag G. The phosphodiesterase PDE4B limits cAMP-associated PI3K\/AKT-dependent apoptosis in diffuse large B-cell lymphoma. Blood, 2005, 105: 308-316.","journal-title":"Blood"},{"key":"null","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/sj.leu.2404594","volume":"21","author":"Renne C","year":"2007","unstructured":"Renne C, Willenbrock K, Martin-Subero JI, Hinsch N, Doring C, Tiacci E, Klapper W. High expression of several tyrosine kinases and activation of the PI3K\/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma. Leukemia, 2007, 21: 780-787.","journal-title":"Leukemia"},{"key":"null","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1189\/jlb.0106014","volume":"80","author":"Zhao LJ","year":"2006","unstructured":"Zhao LJ, Zhang XL, Zhao P, Cao J, Cao MM, Zhu SY, Liu HQ. Up-regulation of ERK and p38 MAPK signaling pathways by hepatitis C virus E2 envelope protein in human T lymphoma cell line. J Leukoc Biol, 2006, 80: 424-432.","journal-title":"J Leukoc Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/leu.2016.13","volume":"30","author":"Nairismagi ML","year":"2016","unstructured":"Nairismagi ML, Tan J, Lim JQ, Nagarajan S, Ng CC, Rajasegaran V, Huang D. JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma. Leukemia, 2016, 30: 1311-1319.","journal-title":"Leukemia"},{"key":"null","author":"Manso R","year":"2017","unstructured":"Manso R, Sanchez-Beato M, Gonzalez-Rincon J, Gomez S, Rojo F, Mollejo M, Garcia-Cosio M. Mutations in the JAK\/STAT pathway genes and activation of the pathway, a relevant finding in nodal Peripheral T-cell lymphoma. Br J Haematol, 2017,","journal-title":"Br J Haematol"},{"key":"null","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.7150\/thno.18345","volume":"7","author":"Gao M","year":"2017","unstructured":"Gao M, Li B, Sun X, Zhou Y, Wang Y, Tompkins VS, Xu Z. Preclinical activity of DCZ3301, a novel aryl-guanidino compound in the therapy of multiple myeloma. Theranostics, 2017, 7: 3690-3699.","journal-title":"Theranostics"},{"key":"null","doi-asserted-by":"crossref","first-page":"e3111","DOI":"10.1038\/cddis.2017.472","volume":"8","author":"Sun X","year":"2017","unstructured":"Sun X, Li B, Xie B, Xu Z, Chang G, Tao Y, Zhang Y. DCZ3301, a novel cytotoxic agent, inhibits proliferation in diffuse large B-cell lymphoma via the STAT3 pathway. Cell Death Dis, 2017, 8:","journal-title":"Cell Death Dis"},{"key":"null","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.2910190505","volume":"19","author":"Schneider U","year":"1977","unstructured":"Schneider U, Schwenk HU, Bornkamm G. Characterization of EBV-genome negative \u2018null\u2019 and \u2018T\u2019 cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer, 1977, 19: 621-626.","journal-title":"Int J Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1182\/blood.V55.3.409.409","volume":"55","author":"Gazdar AF","year":"1980","unstructured":"Gazdar AF, Carney DN, Bunn PA, Russell EK, Jaffe ES, Schechter GPGuccion JG. Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood, 1980, 55: 409-417.","journal-title":"Blood"},{"key":"null","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1022945107762","volume":"8","author":"Ly JD","year":"2003","unstructured":"Ly JD, Grubb DR, Lawen A. The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis, 2003, 8: 115-128.","journal-title":"Apoptosis"},{"key":"null","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/abbs\/gmv094","volume":"47","author":"Yang G","year":"2015","unstructured":"Yang G, Zhang QQ, Kong YY, Xie BQ, Gao MJ, Tao Y, Xu HW. Antitumor activity of fucoidan against diffuse large B cell lymphoma in vitro and in vivo. Acta Biochim Biophys Sin, 2015, 47: 925-931.","journal-title":"Acta Biochim Biophys Sin"},{"key":"null","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00277-010-1022-1","volume":"90","author":"Shi WY","year":"2011","unstructured":"Shi WY, Wang L, Xiao D, Yao Y, Yang F, Jiang XX, Leboeuf C. Proteasome inhibitor bortezomib targeted tumor-endothelial cell interaction in T-cell leukemia\/lymphoma. Ann Hematol, 2011, 90: 53-58.","journal-title":"Ann Hematol"},{"key":"null","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112344","volume":"18","author":"Kalsbeek DG","year":"2017","unstructured":"Kalsbeek DG, olsteyn RM. G2\/M-Phase Checkpoint Adaptation and Micronuclei Formation as Mechanisms That Contribute to Genomic Instability in Human Cells. Int J Mol Sci, 2017, 18:","journal-title":"Int J Mol Sci"},{"key":"null","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1200\/JCO.2016.69.0032","volume":"35","author":"Ingham M","year":"2017","unstructured":"Ingham M, Schwartz GK. Cell-cycle therapeutics come of age. J Clin Oncol, 2017, 35: 2949-2959.","journal-title":"J Clin Oncol"},{"key":"null","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","volume":"116","author":"Danial NN","year":"2004","unstructured":"Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell, 2004, 116: 205-219.","journal-title":"Cell"},{"key":"null","doi-asserted-by":"crossref","first-page":"57870","DOI":"10.18632\/oncotarget.18628","volume":"8","author":"Ouyang ZH","year":"2017","unstructured":"Ouyang ZH, Wang WJ, Yan YG, Wang BLv GH. The PI3K\/Akt pathway: a critical player in intervertebral disc degeneration. Oncotarget, 2017, 8: 57870-57881.","journal-title":"Oncotarget"},{"key":"null","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1756-9966-31-48","volume":"31","author":"Huang Y","year":"2012","unstructured":"Huang Y, Hu J, Zheng J, Li J, Wei T, Zheng Z, Chen Y. Down-regulation of the PI3K\/Akt signaling pathway and induction of apoptosis in CA46 Burkitt lymphoma cells by baicalin. J Exp Clin Cancer Res, 2012, 31:","journal-title":"J Exp Clin Cancer Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.canlet.2011.10.037","volume":"316","author":"Jung KH","year":"2012","unstructured":"Jung KH, Choi MJ, Hong S, Lee H, Hong SW, Zheng HM, Lee HS. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K\/AKT\/mTOR pathway. Cancer Lett, 2012, 316: 187-195.","journal-title":"Cancer Lett"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/19265A4B195842218D627D51774A0D33","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmy047","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/19265A4B195842218D627D51774A0D33","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:53:01Z","timestamp":1660783981000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmy047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,1]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,4,23]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmy047","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4,1]]}}}